Investor Relations

Investor / Media Relations

Businesswoman walking

Genta is committed to identifying, developing and commercializing innovative new products to treat patients with cancer and to address the unmet medical needs of those afflicted with this disease. The shareholders of Genta Incorporated are key partners in this endeavor, and we are very grateful for your investment and confidence in the Company. Genta is committed to keeping our shareholders apprised of new developments from our Company, and we value regular and timely communication with individuals and institutions who own our shares.

To contact Genta Investor Relations, please send your inquiries via email to info@genta.com or phone 908-286-3980.